TEVA241018P15000
- 0.03
- 0.000.00%
Teva Pharmaceutical Industries Newsroom
'Embarassing And Frankly Shameful': Popular Crypto Influencer Slams Kamala Harris's Crypto Regulatory Plan
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26
Donald Trump Extends Betting Odds Lead To 58:42—Here's How Kamala Harris Plans To Reverse The Trend
Immuneering Rises on Orphan Drug Designation for Treatment of Pancreatic Cancer
Trump Vs. Harris: Vice President Goes From Deficit To Slender Lead In New Poll But Battleground States Favor Ex-President, 14% Undecided Voters Up For Grabs
From Sacking Gary Gensler To Spending Crypto Without Incurring Separate Taxation, Top Analyst Has A Wishlist For Kamala Harris On Digital Assets
Trump And Harris Neck-And-Neck In Final Stretch Of Presidential Race, But Here's How Vice President Can Regain Momentum
Kamala Harris Leads Trump, But Most Americans Are Pessimistic About The Nation's Direction, Poll Shows
Bad News For Harris? Early Voting Is Down Drastically From 2020
Kamala Harris Defends Immigration Policy At Latino Town Hall, Criticizes Trump's Border Stance
Kamala Harris Receives $1 Million In XRP From Ripple Co-Founder Chris Larsen
Sector Update: Health Care Stocks Higher Friday Afternoon
Sector Update: Health Care
Harris, Trump Tied in Battle for Swing States, WSJ Poll Shows -- WSJ
Teva Pharmaceuticals to Pay $450M to Settle Kickback Allegations
Express News | 'Drug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing' - DOJ
Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
Trump Vs. Harris: New Poll Shows Pennsylvania May Flip As Vice President's Support Among This Key Group Deteriorates
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...
Trump Vs Harris: Democratic Candidate Holds Narrow Lead Over Ex-president In Tightening Race, New Poll Shows